Vertex Pharmaceuticals Company Info Vertex is in the business of discovering, developing, and commercializing small-molecule drugs for the treatment of serious genetic diseases including cystic fibrosis. News & Analysis The Fool has written over 1,100 articles on Vertex Pharmaceuticals. Featured Article ...
A high-level overview of Vertex Pharmaceuticals Incorporated (VRTX) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
Get Vertex Pharmaceuticals Inc (VRTX:NASDAQ) real-time stock quotes, news, price and financial information from CNBC.
Stay up to date with the latest Vertex Pharmaceuticals Incorporated stock price movements on Seeking Alpha's interactive chart. View comprehensive price data and historical prices on VRTX here.
Vertex Pharmaceuticals Incorporated - BOVESPA:VRTX34 - - - Multiples Valuation: Price / EPS 分享保存 股票价格 701.73 BRL 公允价值 482.40 BRL 看涨 -31.3% Price / LTM EPS Multiple Price / Fwd EPS Multiple Fair Value Benchmark Editor Select Price / LTM EPS Ratio Benchmark Companies ENZN ENTA...
Vertex Pharmaceuticals Stock Forecast, VRTX stock price prediction. Price target in 14 days: 464.623 USD. The best long-term & short-term Vertex Pharmaceuticals share price prognosis for 2023, 2024, 2025, 2026, 2027, 2028 with daily VRTX exchange price p
Pharmaceuticals in the past 3 months VRTX Stock 12 Month Forecast $470.89 ▼(-4.07% Downside) Based on 22 Wall Street analysts offering 12 month price targets for Vertex Pharmaceuticals in the last 3 months. The average price target is $470.89 with a high forecast of $555.00 and a low ...
Our benefits are also unmatched in my experience, the stock offerings, opportunities for bonuses, health coverage (HSA particularly), and maternity leave as well as commuter benefits are incredibly generous.” Read the Great Place To Work Review Courtesy of Vertex Pharmaceuticals Inc. 100 Best ...
Get the latest Vertex Pharmaceuticals Incorporated (VRTX) stock price, news, buy or sell recommendation, and investing advice from Wall Street professionals.
4月12日,纳斯达克上市的生物制药巨头Vertex Pharmaceuticals宣布,计划以每股65美元,总计约49亿美元的价格收购同为美股上市的Alpine公司。该消息一出,Alpine股价当日大幅上涨36.9%,收于64.4美元/股,而Vertex股价亦攀升至400美元/股以上。 此次并购事件不仅在国际市场引发关注,还引起了国内药企巨头的高度兴趣。国内药企已经开...